Home
People
Research
Publications
Links
Contact
Funding
RSS Feed
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.
Revaz Machaidze
October 23, 2015
«
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.
»
News & Events
Craniopharyngioma Trial Continues Enrollment
DRAMATIC CLINICAL RESPONSE TO PD-1 BLOCKADE IN MMR DEFICIENT HIGH-GRADE MENINGIOMA
GERMLINE AND SOMATIC BAP1 MUTATIONS IN HIGH GRADE MENINGIOMA.
HIGHLY MULTIPLEXED IMAGING OF HUMAN TISSUES
Molecular Margins with Metabolite Guide Brain Surgery
PIK3CA MUTATIONS IN MENINGIOMA
TARGETED THERAPY FOR PAPILLARY CRANIOPHARYNGIOMA
Top
